BFC
SRNE

Bedel Financial Consulting’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bedel Financial Consulting’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,480
Closed -$3K – 990
2022
Q1 		$3K Hold
1,480
– – ﹤0.01% 861
2021
Q4 		$7K Buy
+1,480
New +$7K ﹤0.01% 741